NBP vs NBTX

NovaBridge Biosciences vs Nanobiotix S.A. — Valuation Comparison 2026

NBP

Biotechnology
NovaBridge Biosciences
Quality
3.0
out of 10
Value Trap
12
SAFE
Price
$1.87
Last close
Models
9/13
Active
VS

NBTX

Biotechnology
Nanobiotix S.A.
Quality
5.0
out of 10
Value Trap
18
SAFE
Price
$40.41
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType NBP Fair ValueNBP Upside NBTX Fair ValueNBTX Upside
Bayesian DCF Intrinsic $0.37 -80.3% $9.06 -77.6%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $2.15 +14.9% $40.14 -0.7%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for NBP vs NBTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NBP vs NBTX — Which Stock Is More Undervalued?

NBTX scores higher with a 5.0/10 quality rating vs NBP's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NovaBridge Biosciences (NBP) and Nanobiotix S.A. (NBTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NBP currently trades at $1.87 with a QOC of 3.0/10, while NBTX trades at $40.41 with a QOC of 5.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).